We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
The Office of Drug Control will be hosting two information and consultation sessions in July:
- In Brisbane - focusing specifically on the domestic cultivation and manufacture of medicinal cannabis products
- In Adelaide - two sessions looking at clinical issues and then domestic cultivation and manufacture of medicinal cannabis products
Brisbane
| Location | Date | Time | Session information |
|---|---|---|---|
| Commonwealth Department of Health Level 17, 160 Ann Street, Brisbane | 13 July 2017 | 10.00 - 12.00 | Cultivation and manufacture update |
This information and consultation session aims to provide potential cultivators and manufacturers under the Narcotic Drugs Act 1967 with information on:
- Regulation of cultivation, production and manufacture of cannabis for medicinal purposes
- Compliance for licence holders - facility inspections and auditing
- Quality requirements and standards
This session is targeted at those interested in becoming a licensed cultivator or manufacturer of medicinal cannabis products.
Adelaide
| Location | Date | Time | Session information |
|---|---|---|---|
| Adina Treasury Hotel 2 Flinders Street, Adelaide | 18 July 2017 | 09.00 - 12.30 | Medicinal cannabis clinical update |
This information and consultation session aims to provide clinicians and health professionals with an overview of recent reviews of medical evidence and the ongoing development of clinical guidance documents.
In addition, this session will provide an update on current issues around patient access and then on South Australian developments in legislation, regulation, and clinical review processes.
| Location | Date | Time | Session information |
|---|---|---|---|
| Adina Treasury Hotel, 2 Flinders Street, Adelaide | 18 July 2017 | 13.30 - 15.30 | Cultivation and manufacture update |
This information and consultation session aims to provide potential cultivators and manufacturers under the Narcotic Drugs Act 1967with information on:
- Regulation of cultivation, production and manufacture of cannabis for medicinal purposes
- Compliance for licence holders - facility inspections and auditing
- Quality requirements and standards
This session is targeted at those interested in becoming a licensed cultivator or manufacturer of medicinal cannabis products.
Registration
If you wish to register your intent to attend, please email RSVPHPRGExecutive@health.gov.au with the following information:
- Full name of representative/s attending
- Name of organisation
- Position within the organisation
- Phone number and email address of attendees
- Preferred location
- Preferred session
Note: Registrations close on 7 July 2017.
Private discussions on cultivation and manufacture
Following the public discussion, there is an opportunity to meet with the Office of Drug Control privately to discuss existing licences or plans for licence applications under theNarcotic Drugs Act 1967. Note that the Office of Drug Control is unable to provide business advice and that these meetings are to facilitate the discussion of commercially confidential information licence holders or applicants may not wish to raise in the public meeting.
Note that only a limited number of such private meetings are available and that they are reserved for licence holders and licence applicants.
If you wish to register for a private meeting, please indicate that clearly in your registration email.